MRVL Add to watchlist $134.60 +0.77 (+0.58%) Last updated: Apr 16, 2026 00:50
52-Week Range
$134.60
$48.09 $134.60 $138.18

Fundamentals Overview

Marvell Technology, Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 43.2 PEG 0.11 P/B 7.98 P/S 14.36

Intrinsic value (DCF)

-81.5% downside vs price

Profitability

Net margin 32.6%

Risk (Beta)

1.82 — higher vol

Earnings & growth

EPS $3.12 Rev +7% Profit -79.2% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 55% confidence Risk: High Volatility — Beta 1.82. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (5 upgrades) · 3M vs S&P 500: +61.7% · 3M vs Technology sector: +60%

Pressures (Sell):

DCF 81.5% downside vs price · Beta 1.82 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$117.70B
P/E (TTM)
43.16
EPS (TTM)
$3.12
Dividend Yield
0.09%
52-Week Range
$48.09 - $138.18
Volume vs Avg
N/A
Beta
1.82

About

Marvell Technology, Inc., together with its subsidiaries, designs, develops, and sells analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers a portfolio of Ethernet solutions, including controllers, network adapters, physical transceivers, and switches; single or multiple core processors; ASIC; and printer System-on-a-Chip products and application processors. The company also provides a range of storage products comprising storage controllers...
Sector: Technology
Headquarters: US
Employees: 7,042
IPO Date: Jun 2000
Beta: 1.82 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 17, Equal Weight: 2, Hold: 3, Neutral: 2, Outperform: 4, Overweight: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $24.94; current price is $134.60. That’s a -81.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 43.16
DCF value (model) $24.94 (-81.5% vs price)
PEG (TTM) 0.11
P/B (TTM) 7.98
P/S (TTM) 14.36
P/FCF (TTM) 84.42
Liquidity & enterprise
Current Ratio (TTM) 2.01
Quick Ratio (TTM) 1.58
Cash Ratio (TTM) 0.82
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 32.58%
Gross margin (TTM) 50.1%
Operating margin (TTM) 16.26%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for MRVL.

Analyst Sentiment at a Glance

B+ Sentiment Improving
Buy 17Equal Weight 2Hold 3Neutral 2Outperform 4Overweight 2
5 upgrades, 1 downgrade
Price Target Consensus
Current $134.60
Median $120.00
Consensus $125.48
Low consensus $85.00
High consensus $170.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Barclays upgrade Equal Weight Overweight 2026-04-09
Cantor Fitzgerald maintain Neutral Neutral 2026-04-09
Benchmark maintain Buy Buy 2026-03-31
B. Riley Securities maintain Buy Buy 2026-03-06
Stifel maintain Buy Buy 2026-03-06
B of A Securities upgrade Neutral Buy 2026-03-06
TD Cowen maintain Hold Hold 2026-03-06
RBC Capital maintain Outperform Outperform 2026-03-06
Morgan Stanley maintain Equal Weight Equal Weight 2026-03-06
Citigroup maintain Buy Buy 2026-03-06
KGI Securities upgrade Neutral Outperform 2026-03-06
Craig-Hallum maintain Buy Buy 2026-03-06
Benchmark upgrade Hold Buy 2026-03-06
JP Morgan maintain Overweight Overweight 2026-03-06
Rosenblatt maintain Buy Buy 2026-03-06
Evercore ISI Group maintain Outperform Outperform 2026-03-04
Morgan Stanley maintain Equal Weight Equal Weight 2026-03-02
UBS maintain Buy Buy 2026-02-23
Cantor Fitzgerald maintain Neutral Neutral 2026-02-17
UBS maintain Buy Buy 2026-02-03
Citigroup maintain Buy Buy 2026-02-03
Rosenblatt maintain Buy Buy 2026-02-03
Needham maintain Buy Buy 2026-02-03
Benchmark maintain Hold Hold 2026-02-03
Rosenblatt maintain Buy Buy 2026-01-07
Melius Research upgrade Hold Buy 2026-01-05
Benchmark downgrade Buy Hold 2025-12-08
Needham maintain Buy Buy 2025-12-03
Jefferies maintain Buy Buy 2025-12-03
Evercore ISI Group maintain Outperform Outperform 2025-12-03